Risk of Fluctuations in the Market Value of Shares and Other Securities Held
First written in FY2016. 20 of 32 entries say "Mitigated", first in FY2018-Q3. Latest entry: FY2027-H1.
The whole theme swung hardest in 2019: 66 of 143 companies on the "Worse" side.
52 other companies' latest entry also says "Mitigated".
- FY2027-H1MitigatedAnnual report
「Equity financial assets measured at fair value through other comprehensive income Shares 80,053 － 62,519 142,573 Investments － － 6,300 Total 80,053 22,551 68,820 171,424」
Total equity financial assets measured at fair value amounted to ¥171.424 billion, down from ¥178.178 billion at the end of the previous fiscal year. Exposure to market value fluctuation risk decreased. - FY2026MitigatedAnnual report
「In fiscal 2025, the company sold all or part of 5 holdings for ¥2.4 billion, based on market value.」
The Group continued to reduce its cross-shareholdings and again disclosed its policy on sales and its rationale for holding them. Equity instruments measured at fair value at the end of the fiscal year amounted to ¥17,818 million. - FY2026-H1WorsenedAnnual report
「Equity instruments measured at fair value through other comprehensive income Shares 72,986 － 68,362 141,349 Capital contributions － － 5,323 Total 72,986 26,213 73,685 172,886」
Total equity instruments measured at fair value increased from ¥15,871 million at the end of the previous fiscal year to ¥17,288 million, increasing exposure to the risk of fluctuations in market value. - FY2025MitigatedAnnual report
「In fiscal 2024, the company sold all or part of 11 holdings for ¥14.2 billion, based on market value.」
The Group continued to sell cross-shareholdings, reducing exposure to the risk of fluctuations in market value. - FY2025-H1MitigatedAnnual report
「Total 54,081 30,858 70,591 155,531」
Total equity instruments and other assets measured at fair value decreased to ¥15,553 million from ¥17,087 million at the end of the previous fiscal year. Exposure to the risk of fluctuations in market value has decreased. - FY2024MitigatedAnnual report
「In fiscal 2023, the Group sold all or part of its holdings in 16 stocks for ¥21.6 billion, based on market value.」
The Group continued to sell cross-shareholdings and advanced initiatives to reduce exposure to the risk of fluctuations in market value. - FY2024-Q3MitigatedAnnual report
「Equity instruments measured at fair value through other comprehensive income Shares 51,622 － 71,183 122,805 Capital contributions － － 6,991 Total 51,622 37,929 78,175 167,727」
The total fair value of equity instruments decreased to ¥16,773 million from ¥17,475 million at the end of the previous second quarter. Exposure to the risk of fluctuations in market value decreased from the immediately preceding quarter but increased from the end of the fiscal year. - FY2024-Q2WorsenedAnnual report
「Equity instruments measured at fair value through other comprehensive income Shares 49,386 － 71,311 120,698 Capital contributions － － 6,926 Total 49,386 47,134 78,238 174,759」
The total fair value of equity instruments increased to ¥17,475 million from ¥16,056 million at the end of the previous fiscal year. Exposure to the risk of fluctuations in market value has increased. - FY2023MitigatedAnnual report
「During fiscal 2022, the Group sold all or part of its holdings in 30 stocks for ¥27.1 billion, based on market value.」
The Group continued to reduce its cross-shareholdings, selling 30 stocks for ¥27.1 billion during fiscal 2022. - FY2023-Q3MitigatedAnnual report
「Total equity instruments measured at fair value through other comprehensive income amounted to ¥172,223 million.」
The total fair value of equity instruments decreased from ¥18,470 million at the end of the previous fiscal year to ¥17,223 million, reducing exposure to the risk of fluctuations in market value. - FY2023-Q2WorsenedAnnual report
「Equity instruments measured at fair value through other comprehensive income Shares 56,821 － 70,579 127,400 Capital contributions － － 7,182 Total 56,821 60,204 77,761 194,786」
The total fair value of equity instruments increased to ¥19,478 million from ¥18,470 million at the end of the previous fiscal year, increasing exposure to the risk of fluctuations in market value. - FY2023-Q1WorsenedAnnual report
「Equity instruments measured at fair value through other comprehensive income Shares 66,120 － 68,556 134,676 Capital contributions － － 7,305 Total 66,120 53,236 75,862 195,219」
The total fair value of equity instruments increased from ¥18,470 million at the end of the previous fiscal year to ¥19,521 million, increasing exposure to the risk of fluctuations in market value. - FY2022MitigatedAnnual report
「In fiscal 2021, the company sold all or part of 61 holdings for ¥41.9 billion, based on market value.」
Exposure to the risk of fluctuations in the market value of held shares and other assets has been reduced through the sale of cross-shareholdings. - FY2022-Q3MitigatedAnnual report
「Equity instruments measured at fair value through other comprehensive income Shares 68,140 － 64,460 132,601 Capital contributions － － 5,794 Total 68,140 29,488 70,255 167,884」
Total equity instruments decreased to ¥16,788 million from ¥19,880 million at the end of the previous fiscal year. Exposure to the risk of fluctuations in the market value of held shares and other assets decreased. - FY2022-Q2MitigatedAnnual report
「Equity instruments measured at fair value through other comprehensive income Shares 91,967 65,709 157,676 Capital contributions 5,815 Total 191,762」
Total equity instruments decreased to ¥19,176 million from ¥19,880 million at the end of the previous fiscal year, reducing exposure to the risk of fluctuations in market value. - FY2022-Q1WorsenedAnnual report
「Shares 104,419 － 68,041 172,461 Capital contributions － － 6,028」
Equity instruments measured at fair value through other comprehensive income comprised shares of ¥17,246 million and capital contributions of ¥603 million, increasing exposure to the risk of fluctuations in market value from the end of the previous fiscal year. - FY2021MitigatedAnnual report
「To improve the efficiency and effective utilisation of held assets, the Group sold equity instruments measured at fair value through other comprehensive income, resulting in derecognition.」
Equity instruments decreased from ¥22,605 million at the end of the previous fiscal year to ¥16,696 million, while the fair value of sales during the fiscal year was ¥12,828 million. Exposure to the risk of fluctuations in market value has been reduced. - FY2021-Q3MitigatedAnnual report
「Equity instruments measured at fair value through other comprehensive income Shares 93,559 58,738 152,297 Capital contributions 5,429 Total 157,726」
Total equity instruments decreased to ¥157,726 million from ¥226,055 million at the end of the previous fiscal year, reducing exposure to the risk of fluctuations in market value. - FY2021-Q2WorsenedAnnual report
「Equity instruments measured at fair value through other comprehensive income Shares 152,167 53,642 205,810 Capital contributions 6,566 Total 243,989」
Total equity instruments increased to ¥24,389 million from ¥22,605 million at the end of the previous fiscal year. Exposure to the risk of fluctuations in the market value of held shares and other assets has increased. - FY2021-Q1WorsenedAnnual report
「Equity instruments measured at fair value through other comprehensive income Shares 224,749 Capital contributions 6,463 Total 231,212」
Total equity instruments increased from ¥22,605 million at the end of the previous consolidated fiscal year to ¥23,121 million, increasing exposure to the risk of fluctuations in market value. - FY2020MitigatedAnnual report
「Equity instruments measured at fair value through other comprehensive income comprised shares of ¥219.561 billion and capital contributions of ¥6.494 billion, for a total of ¥226.055 billion.」
Total equity instruments decreased from ¥31,881 million in the previous fiscal year to ¥22,605 million, reducing exposure to the risk of fluctuations in the market value of held shares and other assets. - FY2020-Q2MitigatedAnnual report
「Second quarter of the current fiscal year (30 September 2019) Shares 246,127 Capital contributions 6,424 Total 334,984」
Equity instruments measured at fair value through other comprehensive income totaled ¥334.984 billion, down from ¥344.119 billion at the end of the previous fiscal year, reducing exposure to market-value fluctuation risk. - FY2020-Q1MitigatedAnnual report
「Equity instruments measured at fair value through other comprehensive income Shares 246,623 56,011 302,634 Capital contributions 6,560 Total 334,747」
Equity instruments measured at fair value through other comprehensive income totaled ¥334.747 billion, down from ¥344.119 billion at the end of the previous fiscal year. Exposure to market-value fluctuation risk has declined. - FY2019MitigatedAnnual report
「Shares 312,311 Capital contributions 6,499 Total 318,811」
Equity instruments measured at fair value through other comprehensive income totaled ¥318.811 billion, down from ¥355.623 billion in the previous fiscal year. - FY2019-Q3MitigatedAnnual report
「Investment securities 325,413 298,004 Shares of affiliated companies 312,880 334,482」
Investment securities declined, while shares of affiliated companies increased. Their combined total edged down from ¥638.293 billion at the end of the previous fiscal year to ¥632.486 billion. - FY2019-Q2WorsenedAnnual report
「Investment securities 325,413 325,907 Shares of affiliated companies 312,880 328,061」
The carrying amounts of investment securities and shares of affiliated companies increased from the end of the previous fiscal year, expanding exposure to market-value fluctuation risk. - FY2019-Q1WorsenedAnnual report
「Investment securities 325,413 328,828 Shares of affiliated companies 312,880 317,234」
The carrying amounts of investment securities and shares of affiliated companies increased from the end of the previous fiscal year, expanding exposure to market-value fluctuation risk. - FY2018MitigatedAnnual report
「Investment securities 325,413 Shares of affiliated companies 312,880」
The carrying amounts of investment securities and shares of affiliated companies declined from the end of the previous fiscal year, reducing exposure to market-value fluctuation risk. - FY2018-Q3MitigatedAnnual report
「Investment securities 372,196 349,549 Shares of affiliated companies 349,864 327,534」
The consolidated balance-sheet carrying amounts of investment securities and shares of affiliated companies declined from the end of the previous fiscal year, reducing exposure to market-value fluctuation risk. - FY2017RestatedAnnual report
「At the end of the fiscal year, the carrying amount on the consolidated balance sheet of shares and other securities held by the Group was ¥749.1 billion, of which shares and other securities with market values amounted to ¥353.0 billion, with an acquisition cost of ¥200.4 billion.」
The Group continues to disclose the amount held and the amount of shares with market values in relation to market-value fluctuation risk on its shareholdings and other securities. - FY2017-Q1WorsenedAnnual report
「Investment securities 749,177 709,985」
The consolidated balance-sheet carrying amount of investment securities has declined from the end of the previous fiscal year, and the impact of market-value fluctuation risk remains. - FY2016First statedAnnual report
「Fluctuations in the value of the Group's investment securities, including shares, could affect its operating performance and financial position. At the end of the fiscal year, the carrying amount on the consolidated balance sheet of shares and other securities held by the Group was ¥749.1 billion, of which shares and other securities with market values amounted to ¥353.0 billion, with an acquisition cost of ¥200.4 billion.」
The consolidated balance-sheet carrying amount of investment securities declined from ¥970.3 billion in the previous fiscal year to ¥749.2 billion, and the valuation difference on other securities also declined.